Clinical Trial Update: Phase I/IIa Study of Concomitant Radiotherapy With Olaparib and Temozolomide in Unresectable High Grade Gliomas Patients [Phase 1, Phase 2]

View source ↗

Summary

A Phase I/IIa clinical trial is evaluating the safety and feasibility of combining radiotherapy with olaparib and temozolomide in unresectable high-grade glioma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• High-grade Glioma

Drugs mentioned

• Lynparza (olaparib)
• Temodar (Temozolomide)

Snippet

Sponsor: Centre Francois Baclesse | Conditions: Malignant Gliomas, Radiotherapy | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING